News Articles Tagged: BRCA Mutations

Understanding the Mechanism: How Olaparib Targets Cancer Cells

Delve into the intricate mechanism of action of Olaparib, a PARP inhibitor. Learn how it targets BRCA-mutated cancer cells through synthetic lethality and its implications for cancer therapy.

Understanding PARP Inhibitors: Rucaparib's Role in Modern Cancer Therapy

Explore the science behind PARP inhibitors like Rucaparib, their mechanism of action, and their impact on treating BRCA-mutated cancers, particularly ovarian cancer. NINGBO INNO PHARMCHEM CO.,LTD. insights.